WEBULL
News
ABVC
2.410
-4.74%
-0.120
Weekly Report: what happened at ABVC last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at ABVC last week (1117-1121)?
Weekly Report · 11/24 09:24
Weekly Report: what happened at ABVC last week (1110-1114)?
Weekly Report · 11/17 09:24
Weekly Report: what happened at ABVC last week (1103-1107)?
Weekly Report · 11/10 09:24
ABVC BioPharma Q3 EPS $(0.05) Down From $(0.03) YoY, Sales $795.950K Up From $389.276K YoY
Benzinga · 11/03 14:16
ABVC BioPharma Acquires Taiwan Land for $11 Million
Reuters · 11/03 12:31
Weekly Report: what happened at ABVC last week (1027-1031)?
Weekly Report · 11/03 09:23
ABVC Biopharma Ties Executive Compensation to $1B Market Cap Milestone
Reuters · 10/30 12:32
Weekly Report: what happened at ABVC last week (1020-1024)?
Weekly Report · 10/27 09:25
Weekly Report: what happened at ABVC last week (1013-1017)?
Weekly Report · 10/20 09:24
Weekly Report: what happened at ABVC last week (1006-1010)?
Weekly Report · 10/13 09:24
Weekly Report: what happened at ABVC last week (0929-1003)?
Weekly Report · 10/06 09:23
Weekly Report: what happened at ABVC last week (0922-0926)?
Weekly Report · 09/29 09:24
Weekly Report: what happened at ABVC last week (0915-0919)?
Weekly Report · 09/22 09:24
Weekly Report: what happened at ABVC last week (0908-0912)?
Weekly Report · 09/15 10:48
ABVC Biopharma Inc. Issues Correction on Accounting Firm Engagement Status
Reuters · 09/12 10:03
Weekly Report: what happened at ABVC last week (0901-0905)?
Weekly Report · 09/08 10:50
Weekly Report: what happened at ABVC last week (0825-0829)?
Weekly Report · 09/01 10:46
Weekly Report: what happened at ABVC last week (0818-0822)?
Weekly Report · 08/25 10:55
Weekly Report: what happened at ABVC last week (0811-0815)?
Weekly Report · 08/18 10:49
More
Webull provides a variety of real-time ABVC stock news. You can receive the latest news about Abvc Biopharma Inc through multiple platforms. This information may help you make smarter investment decisions.
About ABVC
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on developing products and technologies to combat various diseases. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1702, ABV-1703, ABV- 1501, ABV-1519 and ABV-1701. The Company is developing and researching ABV-1504, a botanical reuptake inhibitor that targets norepinephrine to treat Major Depressive Disorder (MDD). ABV-1505 to treat attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1702 to treat Myelodysplastic syndromes. It has developed an indication for pancreatic cancer from maitake extract, named ABV-1703. ABV-1501 for the treatment of Triple Negative Breast Cancer. ABV-1701 Vitargus for the treatment of Retinal Detachment or Vitreous Hemorrhage. ABV-1519 for the treatment of Non-Small Cell Lung Cancer. It also focuses on the development of new drugs and medical devices derived from plants.